戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  immunofluorescence (DIF)-negative biopsies, be excluded from a diagnosis of MMP.
2 identify low-risk individuals who can safely be excluded from a fracture risk screening program.
3 entified in 341 of 1389 patients, 57 of whom were excluded from additional analyses because of the pr
4       However, this high-risk population has been excluded from all randomized trials evaluating outc
5 an decision post-randomisation; this patient is excluded from all analyses.
6 fenamide group did not receive treatment and was excluded from all analyses.
7                 Systemic lupus erythematosus was excluded from all patients as a potential confounder
8                              Data from seeds were excluded from all analyses.
9 atients with creatinine clearance <25 ml/min were excluded from all the pivotal phase 3 NOAC trials.
10 .27 million for PrEP for male sex workers to be excluded from an optimal portfolio.
11 did not complete the visual analog scale and was excluded from analyses.
12 consent for data use after randomisation and was excluded from analyses.
13 ient developed bacterial endophthalmitis and was excluded from analyses.
14  raltegravir group and one in the NRTI group were excluded from analyses because of ineligibility.
15  more than or less than three different tags were excluded from analyses during Boolean data deconvol
16                                 Participants were excluded from analyses if they had a previous histo
17                                     Patients were excluded from analyses of co-primary endpoints if t
18  and who later had that diagnosis confirmed, were excluded from analyses of pulmonary tuberculosis in
19                                 As affecteds were excluded from analyses, results were not influenced
20 at least one dose of their assigned drug and were excluded from analyses.
21  without cardiometabolic disease at baseline were excluded from analyses.
22                  Of 13,773 pregnancies, 3420 were excluded from analyses.
23 p did not receive study medication, and thus were excluded from analyses.
24 s of 105 did not receive study treatment and were excluded from analyses.
25 and patients with complete remission (14.1%) were excluded from analyses.The proportion of patients w
26 without having had a major adverse event and was excluded from analysis of the primary safety endpoin
27               The first periventricular band was excluded from analysis to mitigate partial volume ef
28        Any SUVmax below the normal threshold was excluded from analysis, as were VOIs not related to
29 hdrew consent before drug administration and was excluded from analysis.
30 1 did not receive any protocol treatment and was excluded from analysis.
31 hort B withdrew before receiving CYP-001 and was excluded from analysis.
32                              Eleven patients were excluded from analysis for a total sample size of 9
33                                     Patients were excluded from analysis if confirmatory imaging was
34          Studies available only as abstracts were excluded from analysis of reporting transparency.
35 s occurring in the terminal inverted repeats were excluded from analysis to prevent double counting,
36 ka cases (missing complete blood count data) were excluded from analysis.
37   Patients with intraoperative complications were excluded from analysis.
38 %) died during the index hospitalization and were excluded from analysis.
39 tillbirths, and higher order multiple births were excluded from analysis.
40 and those who died within 30 days of surgery were excluded from analysis.
41 Patients who died within 3 days of admission were excluded from analysis.
42 nconclusive contrast TTE or MRI, 46 patients were excluded from analysis.
43                           Seven participants were excluded from analysis: three were not properly ran
44      Of the enrolled patients, 1032 patients were excluded from assessment because of incomplete data
45 which encompass 10% of the planet's surface, are excluded from assessments of progress against the St
46                            We find that EXP2 is excluded from, but PfNCR1 is included within these re
47 y extinction), even when B. dracunculifoliae was excluded from calculations.
48 e for but did not complete germline analysis were excluded from calculations of performance character
49                      Patients with TNBC have been excluded from CDK 4/6 inhibitor clinical trials due
50 d by the pollen wall exine, whose deposition is excluded from certain surface areas, the apertures, w
51  transcription factors (TFs) are reported to be excluded from chromosomes.
52 emales and in juvenile mice, which typically are excluded from classic social defeat experiments.
53 transmembrane cargo in mammalian cells, they are excluded from clathrin-coated pits.
54 <50 mg/L cannot be assessed for response and are excluded from clinical trials.
55 ing AAV capsid antibodies and therefore must be excluded from clinical trials or vector readministrat
56 ared decision-making, but cost has generally been excluded from clinical discussions.
57  a hypocellular, matrix-rich tissue that has been excluded from comparative transcriptional atlases.
58 es that contribute to virus replication have been excluded from consideration of a role in latency, p
59           For decades, HIV-infected patients were excluded from consideration for kidney transplantat
60        It is, however, assumed that the PRC1 is excluded from constitutive heterochromatin in somatic
61 supported lipid bilayer, we find that probes are excluded from contact entry in a size-dependent mann
62  investigated how the major phosphatase CD45 is excluded from contact sites, using single-molecule tr
63 A high percentage of patients who would have been excluded from controlled clinical trials undergoes
64 d screening tool, whereby negative specimens are excluded from culture.
65 olerance by demonstrators should continue to be excluded from definitions of teaching, in order to fo
66 is of invasive fungal disease (IFD), but PCR is excluded from disease-defining criteria because of li
67                          Overweight patients were excluded from each cohort for our analysis.
68 udgment is critical, older adults should not be excluded from early revascularization based on age in
69 ection leading to graft failure was seen and was excluded from endothelial cell loss calculation.
70                      Most therapeutic agents are excluded from entering the central nervous system by
71 portunity to be exposed should not routinely be excluded from epidemiologic studies.
72 ling by trapping it in ER-resident foci that are excluded from ER exit sites.
73 with clinically detectable syndromic disease were excluded from evaluation.
74 ggest that some recent field isolates should be excluded from evolutionary studies.
75 hed in EVs versus MSCs, whereas 563 proteins were excluded from EVs.
76 c PCa were prospectively included, of whom 2 were excluded from final analyses.
77           Purpose Children have historically been excluded from first-in-human studies of promising n
78            Currently, such reactions need to be excluded from further analysis because the quantifica
79 temic lupus erythematosus while on study and was excluded from further rhIL-7 dosing.
80  than 1% of people per 1000 person-years and were excluded from further analyses.
81                          Sixty-seven studies were excluded from further analysis because of a final n
82 ch, while producing a desired protein, could be excluded from general translation.
83 y abundant mRNAs encoding ribosomal mRNAs as being excluded from granules.
84 pears to spread evenly along chromosomes but is excluded from heterochromatin.
85          Furthermore, the eggysodontid clade is excluded from hyracodontids and placed as the sister
86                       We show that reporters are excluded from IBs in the presence of the stabilizing
87 nt received the incorrect vaccine, and three were excluded from immunogenicity analyses due to incorr
88 of the anaphase-promoting complex/cyclosome, is excluded from interphase nuclei, but enters nuclei at
89 ,522 (95.5%) received ivermectin, 340 (2.1%) were excluded from ivermectin distribution because of an
90                       344 (2.1%) individuals were excluded from ivermectin treatment because of a hig
91  understood, especially since these patients were excluded from landmark clinical trials.
92 ally screened positive on symptom checklists were excluded from late-onset ADHD diagnosis.
93 tify residual blood in organs; this fraction was excluded from later analysis.
94  building materials) that have traditionally been excluded from LCA.
95  risk for postoperative complications should be excluded from LDLT.
96 ranging from small proteins to large capsids were excluded from liquid FG-Nup droplets, but functiona
97                           Trial participants were excluded from local supplementary immunisation acti
98                                     Patients are excluded from "low-risk" classification and assigned
99  with both asthma and COPD have specifically been excluded from major pharmacologic trials.
100                           Pediatric patients are excluded from most coronavirus disease 2019 (COVID-1
101 rically, patients with brain metastases have been excluded from most clinical trials, but their inclu
102                These patients, however, have been excluded from most heart transplantation research.
103 c data structure of the X chromosome, it has been excluded from most of these analyses.
104              To date, patients with HIV have been excluded from most trials of immune checkpoint bloc
105                                Such patients are excluded from neoadjuvant chemotherapy trials and po
106           It also remains unclear how CENP-A is excluded from non-centromeric chromatin.
107               The most common reason studies were excluded from our analysis was inability to cross-t
108 n hospital or were discharged to hospice and were excluded from our analysis.
109 lve patients who underwent retransplantation were excluded from our efficacy analysis.
110 y in the metastatic setting (not first-line) were excluded from our pooled analyses.
111 ports and limited, retrospective case series were excluded from our review.
112 glaucoma surgery, and <=90 days of follow-up were excluded from outcomes analysis.
113 ies, premature birth, or major comorbidities were excluded from participation.
114 cRCC remains unknown, because these patients were excluded from pivotal studies.
115 ndromes are uncertain because these patients were excluded from pivotal trials.
116 e were presented from clinical trials, which were excluded from primary analyses because patient-leve
117       Eyes with glaucoma or glaucoma suspect were excluded from primary analysis but reported separat
118 retherapeutic (99m)Tc-MAA imaging should not be excluded from radioembolization.
119  a newly defined high-risk blastemal subtype was excluded from randomisation.
120 uiring radiotherapy to an axial primary site were excluded from randomization to avoid excess organ t
121 herapy will lose expression of CD19 and will be excluded from receiving the alternative CD19-targeted
122                           The first 3 months were excluded from rhythm analysis.
123                               How SASP genes are excluded from SAHF-mediated global gene silencing re
124 on of area of naturally disturbed forests to be excluded from salvage logging to conserve biodiversit
125 eligible patients and days on which patients were excluded from SBT eligibility among all mechanicall
126                             53 pupils (0.6%) were excluded from school by age 8 years, and 390 (8.7%)
127            Of those screened, 22 854 (13.1%) were excluded from SDR mainly because of health reasons
128  wild-type counterpart, a G interface mutant is excluded from septin filaments, even at moderate temp
129 sites of nearly ideal A-form structure while being excluded from sites of local deformation in the RN
130 developing asymmetry detected at mammography were excluded from statistical analysis.
131                            Accordingly, Mek1 is excluded from synapsed homologues in wild-type cells.
132 2009 novel influenza A(H1N1) pandemic period was excluded from temporal analyses.
133                             However, cashews are excluded from that claim due to their content of sat
134 and the extent to which the electrolyte ions are excluded from the bundle interior.
135 iphery, but less in the CNS because NK cells are excluded from the CNS.
136 ereas weak or non-nucleosome binding factors are excluded from the domains and enriched in higher mob
137 to the somatic lineages and the germline but are excluded from the extra-embryonic tissues that are d
138 brane proteins reveal that certain molecules are excluded from the GJ plaque (Aquaporin 4, EAAT2b), w
139 polyanions, but have also showed that anions are excluded from the ion atmosphere.
140 rate clade from multituberculate mammals and are excluded from the Mammalia.
141 nes, used as replacement to halons and CFCs, are excluded from the Montreal Protocol because they are
142 ust are certified only for visible smoke and are excluded from the nonvolatile particulate matter (nv
143  and -12; assembled AAV5, -8, and -9 capsids are excluded from the nucleolus, in contrast to the nucl
144                           Shot/Patronin foci are excluded from the oocyte posterior by the Par-1 pola
145 re expressed in transit-amplifying cells but are excluded from the stem cells through inhibition by m
146 mount of human and capital energy should not be excluded from the calculation.
147  in meiosis and that its paralog, CKS1, must be excluded from the germ line for proper embryonic deve
148 ), which is shown by kinetic measurements to be excluded from the Mn(II) binding site.
149 ds that food workers infected with norovirus be excluded from the workplace while symptomatic and for
150 or routine treatment of AGA, most would have been excluded from the pivotal studies that supported US
151               Heavy-duty vehicles have often been excluded from the research scope due to their small
152 e frequent rejections, and the perception of being excluded from the decision-making process; and pay
153 mine N-oxide (TMAO) favor protein folding by being excluded from the vicinity of a protein, whereas d
154                           In contrast, IR40a is excluded from the arista but is expressed (and requir
155  membrane deeply, whereas gamma-aminobutyric is excluded from the bilayer.
156  to the in vitro situation, FOXF1 expression is excluded from the blood islands and blood cells.
157 elicases to bypass blocks on the strand that is excluded from the central channel.
158 nd is encircled by the hexamer and the other is excluded from the central channel.
159 als, while the Eocene genus Montemagrechirus is excluded from the Cryptochiridae and referred to Mont
160 ch spreads along the flanking chromatin, but is excluded from the DSB region.
161 is not a +TIP in cells but, on the contrary, is excluded from the EB1 domain.
162 e (DA) neurons compared to a derivative that is excluded from the nucleus.
163 hat the mRNA of the translation factor eEF1A is excluded from the PGCs in a Nanos2-dependent manner,
164                                  Cholesterol is excluded from the pockets.
165    Moreover, we show that a parasitic strain is excluded from the population during range expansions
166                               However, pUL31 is excluded from the viral nuclear replication center.
167  fulfilled the inclusion criteria; one study was excluded from the analysis due to disconnectedness.
168  (<1%) infant in the no co-trimoxazole group was excluded from the analysis of the final outcomes for
169            One participant in the ECT sample was excluded from the analysis, leaving 67 participants
170 nfection necessitating DBS explantation, and was excluded from the assessment of the primary outcome.
171  Aspergillus polymerase chain reaction (PCR) was excluded from the European Organisation for the Rese
172 lications using the random forest, no sample was excluded from the external validation set.
173 the clinical team before bronchoscopy and so was excluded from the intention-to-treat analysis.
174  assigned to a treatment group; this patient was excluded from the intention-to-treat population) of
175    In both 3T3-L1 and HepG2 cells, GFP-NAMPT was excluded from the nucleus immediately after mitosis
176                                         REC1 was excluded from the nucleus when plants were treated w
177                                   When India was excluded from the sample, the association was only s
178                              One participant was excluded from the trial.
179                                     Patients were excluded from the adjustment group for changes in t
180 ated levels of thyroid peroxidase antibodies were excluded from the analyses (increase in ADHD scores
181  Children who were considered active smokers were excluded from the analyses of salivary cotinine lev
182                             When these peaks were excluded from the analyses, average strombine level
183           Participants with pre-existing CVD were excluded from the analyses.
184                                 Six patients were excluded from the analyses.
185 n group were determined to be ineligible and were excluded from the analyses.
186 l days with PM2.5 concentrations > 30 mug/m3 were excluded from the analysis (0.84% increase in daily
187 ronger when subjects with prevalent diabetes were excluded from the analysis (2.51 [1.37-4.61]; p(tre
188 VAs that occurred during the index admission were excluded from the analysis (hazard ratio, 1.47 [95%
189 arge, centrally overhanging schisis cavities were excluded from the analysis (n = 49) because they un
190                                  Seven cases were excluded from the analysis because of procedural un
191 orty-seven tumors were assessed; five tumors were excluded from the analysis because of technical lim
192                                     Patients were excluded from the analysis if they had less than 1
193 anced glaucoma, and other optic neuropathies were excluded from the analysis of visual acuity, but we
194                             248 participants were excluded from the analysis, and 1753 participants w
195 aromatic hydrocarbons and dibenzothiophenes) were excluded from the analysis, focusing mainly on othe
196 atients with less than 6 months of follow-up were excluded from the analysis, which could have biased
197 e ineligible shortly after randomisation and were excluded from the analysis.
198 nts with incomplete or contaminated cultures were excluded from the analysis.
199 cardiovascular disease and death by casualty were excluded from the analysis.
200 tudy drug, and no randomly assigned patients were excluded from the analysis.
201 ts with any degree of vitreomacular traction were excluded from the analysis.
202 d been confirmed on other imaging modalities were excluded from the analysis.
203                 Two high-intensity practices were excluded from the analysis.
204 ncreas cannot be visualized in 153 cases and were excluded from the analysis.
205 arged within 24 hours after presentation and were excluded from the analysis.
206                   Data of nonfasted patients were excluded from the analysis.
207  > 60 minutes (by Google Maps driving times) were excluded from the analysis.
208  observations were imputed and more subjects were excluded from the analysis.
209 pulse control disorders on dopamine agonists were excluded from the analysis.
210 %) patients did not receive a transplant and were excluded from the analysis.
211            Patients with acute liver failure were excluded from the analysis.
212 ntrol group) who were re-randomised in error were excluded from the analysis.
213 ion between birth and 24-month follow-up and were excluded from the analysis.
214 her 6 month or 12 month follow-up visits and were excluded from the analysis: three from the PLTR gro
215                              If fruit juices were excluded from the category of sugar-sweetened bever
216 copathologic features included in some tests were excluded from the comparisons.
217 ncident cases of dementia over the follow-up were excluded from the control population.
218 -three patients were older than 65 years and were excluded from the cutoff analysis.
219 up and one patient in the radiotherapy group were excluded from the efficacy analysis because they we
220   Four patients had inclusion violations and were excluded from the efficacy analysis, which thus inc
221 t the inclusion criteria; these participants were excluded from the efficacy analysis.
222 June 13, 2014, and Oct 27, 2014; 11 patients were excluded from the evaluable for response analysis s
223  Two patients with the LRRK2 G2019S mutation were excluded from the final analysis.
224 cesses have not been extensively studied and were excluded from the Infant Aphakia Treatment Study (I
225 However, unlike T cells, anti-myelin B cells were excluded from the inflamed tissue.
226        Of 649 patients enrolled, 22 patients were excluded from the intent-to-treat analysis.
227                                Five patients were excluded from the intention-to-treat population (3
228 ents were enrolled at more than one site, so were excluded from the intention-to-treat population (CO
229            Two patients in the placebo group were excluded from the intention-to-treat population for
230              Around 11% of high-risk infants were excluded from the LEAP study because of an SPT whea
231 who had chronic diseases other than diabetes were excluded from the main analysis.
232 n level, platelet count, and body mass index were excluded from the main models because of high numbe
233                        Overall, 7436 (38.4%) were excluded from the metric.
234 h organic disease identified after enrolment were excluded from the modified intention-to-treat popul
235  with viral vectors mediating Lhx1 knockdown were excluded from the nephric tubules, whereas cells tr
236        Patients with severe renal impairment were excluded from the non-VKA oral anticoagulant trials
237  Unreliable results (assessed qualitatively) were excluded from the normative data analysis.
238  atrophy component and demographic variables were excluded from the optimal predictive model of cogni
239 nts with bicuspid aortic valve (AV) stenosis were excluded from the pivotal evaluations of transcathe
240 ation and severely decreased kidney function were excluded from the pivotal non-vitamin K antagonist
241                                 Participants were excluded from the prediction analysis if they had a
242 birth group and three in the expectant group were excluded from the primary analyses.
243                              23 kidney pairs were excluded from the primary analysis because of kidne
244       Eyes with glaucoma or glaucoma suspect were excluded from the primary analysis but reported sep
245 buting a post-randomisation BCVA measurement were excluded from the primary analysis population and f
246 ents receiving grazoprevir and elbasvir, six were excluded from the primary efficacy analysis for non
247  participants in the study; ten participants were excluded from the primary hormone analysis.
248 ng a post-randomisation BCVA measurement and were excluded from the primary outcome analysis populati
249                                     Patients were excluded from the primary safety analysis if they d
250  pancreatic ductal adenocarcinoma (PDAC) and were excluded from the recurrence analysis.
251 age that did not have an abstract in English were excluded from the review.
252 ment (two patients in the tremelimumab group were excluded from the safety population because they di
253          Of these patients, 20 (5%) patients were excluded from the study (16 [4%] patients did not m
254 patients involved in 1563 self-harm episodes were excluded from the study because they had missing in
255 (pos) MUXF3(pos) but Pla a 1/2(neg) subjects were excluded from the study because they were cross-rea
256 individuals were assessed and 37 916 (61.3%) were excluded from the study because they were outside o
257            Seven samples of tumor resections were excluded from the study because they were studied b
258                   A total of 523 individuals were excluded from the study cohort because they decline
259                                     Children were excluded from the study if they had coexisting gast
260  data to render a diagnosis, 1.7% (7 of 401) were excluded from the study, and 6.0% (24 of 401) refus
261 t once before their 15th birthday (n = 5882) were excluded from the study.
262 dication or hormonal treatment for hair loss were excluded from the study.
263 th perforation/impending corneal perforation were excluded from the study.
264                      Samples below 100 IU/ml were excluded from the study.
265  ocular surface disease, and multiple grafts were excluded from the study.
266 y-eight eyes did not meet study criteria and were excluded from the study.
267 completely brown after 28days of storage and were excluded from the study.
268 atients with OA-DLBCL were identified, and 6 were excluded from the study.
269 Foetuses with structural brain abnormalities were excluded from the study.
270 ital anomalies, or chromosomal abnormalities were excluded from the study.
271 surgery or active retinal neovascularization were excluded from the study.
272  presented with colour loss or heterogeneity were excluded from the study.
273 adiographs (>75%) were non-interpretable and were excluded from the study.
274  pylori was identified in 368 samples, which were excluded from the study.
275 d those born as a result of induced abortion were excluded from the study.
276  that required systemic therapy at screening were excluded from the study; however, 1 participant dev
277 rdiac sarcoidosis and those <15 years of age were excluded from the subanalysis.
278 osed at autopsy or with an unknown follow-up were excluded from the survival analysis, leaving 231684
279    Patients with initially low visual acuity were excluded from the therapy approval studies for reti
280 after a major bleeding or surgical procedure were excluded from the time at risk.
281  sites that were judged as not having cancer were excluded from the training set and only individuals
282 ) of the cases of the stroke database, which were excluded from the training set.
283                                     Patients were excluded from the trial if they had a history of li
284 e mitral stenosis or mechanical heart valves were excluded from the trial.
285 than 1 week before the surgical consultation were excluded from the trial.
286 Subjects with uncontrolled and severe asthma were excluded from the trials.
287 and other conserved non-coding RNAs (ncRNAs) are excluded from these bodies.
288 teractions with Complex I and cytochrome b6f are excluded from these regions of the membrane, so PSI
289  of actively transcribed genes, whereas PRC2 is excluded from these regions; this suggests that H3K27
290  patients with missing baseline HFMSE scores were excluded from these analyses.
291 on complexes between metal ions and peptides are excluded from this review.
292 antly variable by cancer type (hypermutation is excluded from this study).
293 mission within 3 years of entry to the study were excluded from this analysis.
294 the delayed treatment group (two individuals were excluded from this group after randomisation).
295 ws, conference abstracts and grey literature were excluded from this metasynthesis.
296                    The 16 level III articles were excluded from this review.
297 present in the stromal area of the tumor and are excluded from tumoral area compared with melanoma, w
298        Relative to CE, both apoAI and apoAII were excluded from uptake by all cells.
299 y or a causal pathogenic copy number variant were excluded from WES analyses.
300 rkers and 0% of postsymptomatic food workers were excluded from work.

 
Page Top